File Download
  Patent History
  • Application
    CN 20078040670 2007-11-28
  • Publication
    CN 101553728 2009-10-07
Supplementary

published patent: The use of granulin-epithelin precursor (GEP) antibodies for detection and suppression of hepatocellular carcinoma (HCC)

TitleThe use of granulin-epithelin precursor (GEP) antibodies for detection and suppression of hepatocellular carcinoma (HCC)
Priority Date2006-11-28 US 11/861318P
Inventors
Issue Date2009
Citation
China Published Patent Application CN 101553728. Beijing, PRC: State Intellectual Property Office (SIPO) of the P.R.C., 2009 How to Cite?
AbstractThis invention provides methods for detecting serum GEP level. This invention further provides methods for determining whether a subject is afflicted with Hepatocellular carcinoma (HCC) by measuring serum GEP level. In another embodiment, this invention provides methods for the suppression of HCC growth and progression both in vitro and in vivo by treating a patient with anti-GEP monoclonal antibody A23.
Persistent Identifierhttp://hdl.handle.net/10722/176624

 

DC FieldValueLanguage
dc.date.accessioned2012-11-30T08:38:15Z-
dc.date.available2012-11-30T08:38:15Z-
dc.date.issued2009-
dc.identifier.citationChina Published Patent Application CN 101553728. Beijing, PRC: State Intellectual Property Office (SIPO) of the P.R.C., 2009en_HK
dc.identifier.urihttp://hdl.handle.net/10722/176624-
dc.description.abstractThis invention provides methods for detecting serum GEP level. This invention further provides methods for determining whether a subject is afflicted with Hepatocellular carcinoma (HCC) by measuring serum GEP level. In another embodiment, this invention provides methods for the suppression of HCC growth and progression both in vitro and in vivo by treating a patient with anti-GEP monoclonal antibody A23.en_HK
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documentsen_US
dc.titleThe use of granulin-epithelin precursor (GEP) antibodies for detection and suppression of hepatocellular carcinoma (HCC)en_HK
dc.typePatenten_US
dc.description.naturepublished_or_final_versionen_US
dc.identifier.hkuros164790-
dc.contributor.inventorCheung, STen_HK
dc.contributor.inventorHo Chung Yee Jennyen_HK
dc.contributor.inventorFan, STen_HK
patents.identifier.applicationCN 20078040670en_HK
patents.description.assigneeUNIV HONG KONG [HK]en_HK
patents.description.countryChina, PRCen_HK
patents.date.publication2009-10-07en_HK
patents.date.application2007-11-28en_HK
patents.date.priority2006-11-28 US 11/861318Pen_HK
patents.description.ccCNen_HK
patents.identifier.publicationCN 101553728en_HK
patents.relation.familyCN 1950521 (A) 2007-04-18en_HK
patents.relation.familyCN 101553728 (A) 2009-10-07en_HK
patents.relation.familyUS 2005244839 (A1) 2005-11-03en_HK
patents.relation.familyUS 2008199470 (A1) 2008-08-21en_HK
patents.relation.familyWO 2005106019 (A1) 2005-11-10en_HK
patents.relation.familyWO 2008064570 (A1) 2008-06-05en_HK
patents.description.kindAen_HK
patents.typePatent_publisheden_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats